Royalty Pharma’s total revenue increased from $538.5 million earned in Q3 2020 to $585.7 million earned in Q3 2021, marking an 8.7% growth on a year-on-year basis. It also grew by 5.5% on a quarterly basis, as compared to $554.9 million earned in Q2 2021. Royalty Pharma’s revenue is further bifurcated into the following segments:
According to Royalty Pharma 's latest financial reports the company's current revenue (TTM) is $2.28 B . In 2020 the company made a revenue of $2.12 B an increase over the years 2019 revenue that were of $1.81 B .The revenue is the total amount of income that a company generates by the sale of goods or services.
Get the detailed quarterly/annual income statement for Royalty Pharma plc (RPRX). Find out the revenue, expenses and profit or loss over the last fiscal year.
DA:45PA:19MOZ Rank:54
Royalty Pharma’s Competitors, Revenue, Number of …
Royalty Pharma generates $2.3B in revenue How much funding does Royalty Pharma have? Royalty Pharma has historically raised $8.9B in funding Where is Royalty Pharma's headquarters? Royalty Pharma's headquarters is in New York New York, USA How many employees does Royalty Pharma have? Royalty Pharma has 5 employees
As of Q2 2022, ROYALTY PHARMA's earnings has grown -4% year over year. This is 216.06 percentage points lower than the US Biotechnology industry earnings growth rate of 212.06%. ROYALTY PHARMA's earnings in the past year totalled $602.37 million.
Jun 19, 2020 · Royalty Pharma managed $10bn in assets by 2013, a figure that grew to $16bn by 2019. According to the company’s financial reports, Royalty Pharma’s net income rose from $581m in 2015 to $2.35bn in 2019. In the first quarter of 2020, the firm’s revenue surged 15 per cent year-on-year to a whopping $500.9m. Royalty Pharma IPO details
DA:27PA:4MOZ Rank:80
Royalty Pharma Company Profile | Management and Employees List
Royalty Pharma AG Royalty Pharma Investor Relations and Communicatio... RP Management LLC Revenue $2.3 B Employees 66 Founded 1996 Primary Industries Business Services Research & Development Finance CEO Pablo Legorreta Stock Symbol NASDAQ: RPRX Royalty Pharma Executive Team & Key Decision Makers Show Me More Executives Recently …
